awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36721696-43D871CF-B7C0-41E1-8A31-6D8C9117AC5B
Q36721696-43D871CF-B7C0-41E1-8A31-6D8C9117AC5B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36721696-43D871CF-B7C0-41E1-8A31-6D8C9117AC5B
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)
P2860
Q36721696-43D871CF-B7C0-41E1-8A31-6D8C9117AC5B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36721696-43D871CF-B7C0-41E1-8A31-6D8C9117AC5B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
24f728ec2514f808971a8d8eb678e92cd34eede3
P2860
Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation.